Gerard Michel's Trading History
| BBNXBeta Bionics, Inc. | May 26, 2026 | Director | Uninformative Buy | ― | $561.28K | |
| DCTHDelcath Systems | Mar 03, 2026 | CEO, Director | Informative Buy | 100.24K | $4.80M | |
| VCELVericel | Feb 10, 2020 | CFO and VP, Corp. Development | Uninformative Buy | 26.61K | $6.49M | |
| ALBOAlbireo Pharma | Oct 02, 2012 | ― | Uninformative Buy | 35.03K | $1.93M | |
| NPSPNPS Pharma | ― | ― | ― | ― |
You May Also Like
Gerard Michel insider profile FAQ
What is the percentage of profitable transactions made by Gerard Michel?
The percentage of profitable transactions made by Gerard Michel is 46%.
What is the average return per transaction made by Gerard Michel?
The average return per transaction made by Gerard Michel is 23.30%.
What stocks does Gerard Michel hold?
Gerard Michel holds: BBNX, VCEL, DCTH, ALBO, NPSP stocks.
What was Gerard Michel's most profitable transaction?
Gerard Michel’s most profitable transaction was an Informative Buy of DCTH stock on December 11, 2023. The return on the trade was 327.50%.
What is Gerard Michel's role in Beta Bionics, Inc.?
Gerard Michel's role in Beta Bionics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.